PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 187 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 5.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $757,000 | -70.1% | 106,225 | +0.3% | 0.07% | -64.1% |
Q4 2019 | $2,528,000 | -10.4% | 105,856 | +0.6% | 0.19% | -18.6% |
Q3 2019 | $2,822,000 | +75.9% | 105,212 | +77.8% | 0.24% | +81.5% |
Q2 2019 | $1,604,000 | -20.6% | 59,159 | +1.6% | 0.13% | -23.1% |
Q1 2019 | $2,020,000 | -24.5% | 58,219 | -57.5% | 0.17% | -29.6% |
Q4 2018 | $2,675,000 | – | 137,052 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |